Literature DB >> 17220479

CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse.

Nicolas Espagnolle1, David Depoil, Rossana Zaru, Cecile Demeur, Eric Champagne, Martine Guiraud, Salvatore Valitutti.   

Abstract

Upon conjugation with cognate antigen-presenting cells (APCs), T lymphocytes undergo a sustained [Ca(2+)](i) increase resulting from the engagement of TCR and of accessory molecules with ligands expressed on the surface of APCs. We investigated the contribution of the accessory molecule CD2 to the activation of phospholipase Cgamma1 (PLCgamma1)/calcium pathway in antigen-stimulated T cells. We show that CD2 binding with its ligand CD58 expressed on the surface of APCs augments and sustains antigen-induced [Ca(2+)](i) increase in individual T cells interacting with APCs. We also show that in conditions in which CD2-CD58 interaction is impeded, the recruitment of PLCgamma1 to the immunological synapse (IS) is reduced. Interestingly, in these conditions PLCgamma1 phosphorylation in the regulatory tyrosine 783 is also defective. Our results indicate that TCR- and CD2-derived signals converge for the recruitment and activation of PLCgamma1 at the IS and shed new light on the accessory function of CD2 in T cell activation by specific antigen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220479     DOI: 10.1093/intimm/dxl141

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  18 in total

1.  Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Authors:  Matthias T Stephan; Sirkka B Stephan; Peter Bak; Jianzhu Chen; Darrell J Irvine
Journal:  Biomaterials       Date:  2012-05-15       Impact factor: 12.479

Review 2.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

3.  Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58.

Authors:  Johanna Veldman; Lydia Visser; Magdalena Huberts-Kregel; Natasja Muller; Bouke Hepkema; Anke van den Berg; Arjan Diepstra
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

4.  Inhibition of cell adhesion and immune responses in the mouse model of collagen-induced arthritis with a peptidomimetic that blocks CD2-CD58 interface interactions.

Authors:  Ameya S Gokhale; Rushikesh Sable; Jason D Walker; Leslie McLaughlin; Konstantin G Kousoulas; Seetharama D Jois
Journal:  Biopolymers       Date:  2015-11       Impact factor: 2.505

Review 5.  Phosphoinositide-specific phospholipase C in health and disease.

Authors:  Lucio Cocco; Matilde Y Follo; Lucia Manzoli; Pann-Ghill Suh
Journal:  J Lipid Res       Date:  2015-03-27       Impact factor: 5.922

6.  Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.

Authors:  Eun-Ok Kim; Tae-Jin Kim; Nayoung Kim; Sung Tae Kim; Vinay Kumar; Kyung-Mi Lee
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

7.  Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells.

Authors:  James C Stone
Journal:  Genes Cancer       Date:  2011-03

Review 8.  Functional anatomy of T cell activation and synapse formation.

Authors:  David R Fooksman; Santosh Vardhana; Gaia Vasiliver-Shamis; Jan Liese; David A Blair; Janelle Waite; Catarina Sacristán; Gabriel D Victora; Alexandra Zanin-Zhorov; Michael L Dustin
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

9.  Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition.

Authors:  Ching Y Voss; Sara Deola; Thomas A Fleisher; Francesco M Marincola
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  Modulation of co-stimulatory signal from CD2-CD58 proteins by a grafted peptide.

Authors:  Pravin Parajuli; Rushikesh Sable; Leeza Shrestha; Achyut Dahal; Ted Gauthier; Veena Taneja; Seetharama Jois
Journal:  Chem Biol Drug Des       Date:  2020-10-02       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.